Open | $10.510 |
Close | $10.720 |
Volume / Avg. | 333.404K / 517.596K |
Day Range | 10.100 - 11.163 |
52 Wk Range | 3.888 - 14.040 |
Market Cap | $250.063M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 7.52% |
Days to Cover | 3.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inovio Pharmaceuticals (NASDAQ: INO) through any online brokerage.
Other companies in Inovio Pharmaceuticals’s space includes: bluebird bio (NASDAQ:BLUE), Gritstone Bio (NASDAQ:GRTS), Mesoblast (NASDAQ:MESO), Agenus (NASDAQ:AGEN) and Opthea (NASDAQ:OPT).
The latest price target for Inovio Pharmaceuticals (NASDAQ: INO) was reported by Oppenheimer on Friday, March 8, 2024. The analyst firm set a price target for 40.00 expecting INO to rise to within 12 months (a possible 273.83% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $10.7 last updated March 18, 2024 at 7:42 PM EDT.
There are no upcoming dividends for Inovio Pharmaceuticals.
Inovio Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Inovio Pharmaceuticals.
Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.